(Q42547819)

2 November 2017

Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion (English)

1 reference

2 November 2017

Vanover KE

1

1 reference

PubMed ID

9286612

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

European Journal of Pharmacology

2 November 2017

1 reference

2 November 2017

332

1 reference

2 November 2017

2

1 reference

2 November 2017

115-119

1 reference

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Amelioration of negative symptoms in schizophrenia by glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Facilitation of olfactory learning by a modulator of AMPA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

Facilitation of glutamate receptors enhances memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901103-5

10.1016/S0014-2999(97)01103-5

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference

PubMed ID

9286612